Next report date
Report period
Q2 2024
EPS estimate
−0.21EUR
Revenue estimate
281.30 KEUR
−23.82 MEUR
811.31 KEUR
15.70 M
Om Mainz Biomed N.V.
Sektor
Bransch
VD
Guido Baechler
Webbplats
Huvudkvarter
Mainz
Grundat
2021
ISIN
NL0015000LC2
FIGI
BBG013CXKZ88
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
